AU2159895A - Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains - Google Patents
Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domainsInfo
- Publication number
- AU2159895A AU2159895A AU21598/95A AU2159895A AU2159895A AU 2159895 A AU2159895 A AU 2159895A AU 21598/95 A AU21598/95 A AU 21598/95A AU 2159895 A AU2159895 A AU 2159895A AU 2159895 A AU2159895 A AU 2159895A
- Authority
- AU
- Australia
- Prior art keywords
- domains
- materials
- methods
- molecular interactions
- identifying inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
- C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/72—Fusion polypeptide containing domain for protein-protein interaction containing SH2 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20983594A | 1994-03-11 | 1994-03-11 | |
US209835 | 1994-03-11 | ||
US36983295A | 1995-01-06 | 1995-01-06 | |
US369832 | 1995-01-06 | ||
PCT/US1995/003208 WO1995024419A1 (en) | 1994-03-11 | 1995-03-13 | Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2159895A true AU2159895A (en) | 1995-09-25 |
Family
ID=26904553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21598/95A Abandoned AU2159895A (en) | 1994-03-11 | 1995-03-13 | Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0750630A4 (en) |
AU (1) | AU2159895A (en) |
WO (1) | WO1995024419A1 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0772773B1 (en) * | 1994-07-22 | 2006-04-05 | The University Of North Carolina | Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
US6184205B1 (en) * | 1994-07-22 | 2001-02-06 | University Of North Carolina At Chapel Hill | GRB2 SH3 binding peptides and methods of isolating and using same |
US6303574B1 (en) | 1994-07-22 | 2001-10-16 | The University Of North Carolina At Chapel Hill | Scr SH3 binding peptides and methods of isolating and using same |
US5888763A (en) * | 1994-12-30 | 1999-03-30 | The Rockefeller University | Peptides specific for the first Crk-SH3 domain |
US6309820B1 (en) | 1995-04-07 | 2001-10-30 | University Of North Carolina At Chapel Hill | Polypeptides having a functional domain of interest and methods of identifying and using same |
AU711141B2 (en) * | 1995-04-07 | 1999-10-07 | Cytogen Corporation | Polypeptides having a functional domain of interest and methods of identifying and using same |
GB2311067B (en) * | 1996-01-08 | 2000-03-29 | Yamanouchi U K Ltd | Proline rich peptides derived from the rasgap-associated protein P62 |
AU2053197A (en) * | 1996-02-23 | 1997-09-10 | Ariad Pharmaceuticals, Inc. | Cell-based assay |
US7279548B2 (en) | 1996-04-03 | 2007-10-09 | Cytogen Corporation | Identification and isolation of novel polypeptides having WW domains and methods of using same |
US5928868A (en) * | 1996-04-26 | 1999-07-27 | Massachusetts Institute Of Technology | Three hybrid screening assay |
US6723694B1 (en) * | 1997-05-21 | 2004-04-20 | The Children's Medical Center Corp. | Short peptides which selectively modulate intracellular signalling |
EP1077997A2 (en) * | 1998-05-21 | 2001-02-28 | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING (McGILL UNIVERSITY) | Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
EP1181358B1 (en) | 1999-05-26 | 2010-11-17 | Next Biomed Technologies NBT Oy | Methods and materials for generating sh3 domains with tailored binding properties |
US20020002239A1 (en) * | 1999-12-29 | 2002-01-03 | Tanaka Richard D. | Binding of polyamides to proteins having SH3 or WW domains |
JP4383855B2 (en) * | 2001-07-02 | 2009-12-16 | メリオン リサーチ スリー リミテッド | Ligands that target Peyer's patches and / or M cells |
WO2003006043A1 (en) * | 2001-07-10 | 2003-01-23 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
AU2003258022A1 (en) | 2002-08-02 | 2004-02-23 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
US7265129B2 (en) | 2002-10-25 | 2007-09-04 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
EP1587529A4 (en) | 2002-12-10 | 2009-08-12 | Oscient Pharmaceuticals Corp | Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
CN101208353B (en) | 2003-06-20 | 2011-12-14 | 梅约医学教育与研究基金会 | Isoforms of brain natriuretic peptide |
CN101501067B (en) | 2006-08-08 | 2013-01-16 | 梅约医学教育与研究基金会 | Diuretic and natriuretic polypeptides |
AU2008291682B2 (en) * | 2007-08-24 | 2012-09-13 | Mylexa Pty Limited | Modulators of hypersensitivity reactions |
WO2009036448A2 (en) | 2007-09-15 | 2009-03-19 | Mayo Foundation For Medical Education And Research | Natriuretic peptide receptor-c agonists |
US8088890B2 (en) * | 2008-09-26 | 2012-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
JP2014525439A (en) | 2011-08-30 | 2014-09-29 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | Natriuretic polypeptide |
WO2013103896A1 (en) | 2012-01-06 | 2013-07-11 | Mayo Foundation For Medical Education And Research | Treating cardiovascular or renal diseases |
EP2752196A1 (en) * | 2013-01-03 | 2014-07-09 | Université Bordeaux Segalen | Selective nox-1 inhibitor peptides and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5283173A (en) * | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
CA2054602C (en) * | 1991-10-31 | 2003-04-22 | Anthony Pawson | Method for assaying for a substance that affects an sh2-phosphorylated ligand regulatory system |
-
1995
- 1995-03-13 AU AU21598/95A patent/AU2159895A/en not_active Abandoned
- 1995-03-13 EP EP95914721A patent/EP0750630A4/en not_active Withdrawn
- 1995-03-13 WO PCT/US1995/003208 patent/WO1995024419A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1995024419A1 (en) | 1995-09-14 |
EP0750630A4 (en) | 1998-01-07 |
EP0750630A1 (en) | 1997-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2159895A (en) | Methods and materials for identifying inhibitors of molecular interactions mediated by sh3 domains | |
HUP9700602A3 (en) | New inhibitors of bone-resorption and vitronectine-receptor-antagonists | |
AU3395597A (en) | Identification and comparison of protein-protein interactions and inhibitors thereof | |
AU2819397A (en) | Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same | |
AU6977998A (en) | Method and apparatus for ionized sputtering of materials | |
IL122186A (en) | Heterocycles as inhibitors of leucotype adhesion and as vla-4-antagonists | |
AU2996897A (en) | Inhibitors of microsomal triglyceride transfer protein and method | |
AU4231197A (en) | Hppd gene and inhibitors | |
HUP9901321A3 (en) | Methods and compositions for determining the sequence of nucleic acid molecules | |
AU3793697A (en) | Apparatus and methods for the disinfection of fluids | |
AU6136094A (en) | Apolipoprotein b mrna editing protein compositions and methods | |
AUPN992596A0 (en) | Magnetic detection of discontinuities in magnetic materials | |
AU6659698A (en) | Compositions, methods, kits and apparatus for determining the presence or absence of target molecules | |
AU3294897A (en) | Method and apparatus for sensing the presence of microbes | |
AU2967692A (en) | Improved composition and device for urinary protein assay and method of using the same | |
AU6485996A (en) | Methods and compositions for modulation and inhibition of teomerase | |
AU5599598A (en) | Inhibitors of glycosyltransferases | |
AU4634896A (en) | Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods | |
AU4499997A (en) | Novel morphogen-responsive signal transducer and methods of use thereof | |
AU9589798A (en) | Composition and method for inhibiting polymerization during the anaerobic production of styrene | |
AU5654696A (en) | Inhibitors of fibrin cross-linking and/or transglutaminases | |
AU4064897A (en) | Mammalian ribonuclease inhibitors and use thereof | |
AU7395194A (en) | Neomorphic ibuprofen and methods of using same | |
AU2479495A (en) | Materials and methods for the detection of mycobacteria | |
AU8010698A (en) | Method and device for enabling non-destructive determination of the elasticity of materials |